Table 3.
Endoscopic retrograde cholangiopancreatography (ERCP) procedure characteristics (n = 132)
| Indication for ERCP, n (%) | |
| Anastomotic stricture | 60 (45.5) |
| Abnormal or worsening LFTs | 29 (22.0) |
| Bile leak | 15 (11.4) |
| Cholangitis | 13 (9.8) |
| Stones or cast | 9 (6.8) |
| Non‐anastomotic stricture | 4 (3.0) |
| Other † | 2 (1.5) |
| Interventions used, n (%) | |
| Antibiotic prophylaxis | 123 (93.2) |
| Rectal indomethacin | 19 (14.4) |
| Sphincterotomy | 47 (35.6) |
| Sphincteroplasty | 1 (0.8) |
| Common bile duct cannulation | 129 (97.7) |
| Balloon or basket dredging | 83 (62.9) |
| Pancreatic duct cannulation | 13 (9.8) |
| Pancreatic duct injection | 2 (1.5) |
| Pancreatic duct stent | 9 (6.8) |
| Dilation of bile duct—anastomotic stricture | 44 (33.3) |
| Dilation of bile duct—non‐anastomotic stricture | 12 (9.1) |
| Any biliary stent used, n (%) | 98 (74.2) |
| Type of biliary stent (n = 98), n (%) | |
| Plastic | 92 (93.9) |
| Kaffes intraductal stent | 4 (4.1) |
| SEMS | 2 (2.0) |
| Number of biliary stent(s) if plastic stent(s) (n = 92), n (%) | |
| 1 | 75 (81.5) |
| 2 | 10 (10.9) |
| 3 | 6 (6.5) |
| 4 | 0 (0) |
| 5 | 1 (1.1) |
| Cholangioscopy, n (%) | 3 (2.3) |
| Cholangioscopy indication (n = 3), n (%) | |
| Common bile duct stone | 2 (66.7) |
| Stricture cannulation | 1 (33.3) |
LFTs, liver function tests; SEMS, self‐expandable metallic stent.
†
Other indications for ERCP include: T tube removal and suspected collection/biloma.